Amakem NV, a kinase platform company focusing on ophthalmology, today announces that it has initiated a Phase 2a proof of concept study of its novel Rho Kinase (ROCK) inhibitor, AMA0076, in patients with glaucoma and ocular hypertension.
Category: News
Cost of glaucoma revealed
The first 6 months after an open-angle glaucoma diagnosis are the most costly within the first 2 years of having the condition, report US researchers.
FDA Panel to Review Safety of Eye Device
WASHINGTON (MedPage Today) — FDA reviewers expressed concern over the long-term safety of what could be the first retinal prosthesis device despite evidence that it helps improve the vision of some patients.
Retinopathy Provides Window Into Chronic Kidney Disease
A strong association between retinopathy and chronic kidney disease suggests a noninvasive eye examination could play a role in the diagnosis of renal dysfunction. Medscape Medical News
Dexamethasone use during tonsillectomy not associated with excessive bleeding in children
Tonsillectomy is exceedingly common, with a reported increase in tonsillectomy rates in children younger than 15 years from 287,000 to 530,000 per year over the past decade. Although safe, adenotonsillectomy can result in significant complications, suc…
Magnetic Factor Aids Therapeutic Impact Of Cell Transplantation
Two studies in the current issue of Cell Transplantation (21:6), now freely available on-line,* demonstrate how the use of magnetic particles are a factor that can positively impact on the targeted delivery of transplanted stem cells and to also provid…
Natural Defence Against Infection Discovered In The Cornea
Exposed tissue surfaces, including skin and mucous membranes, are under constant threat of attack by microorganisms in the environment. The layer of cells that line these areas, known as epithelial cells, are the first line of defense against these pat…
STAAR Surgical to participate in 88th Congress of the Society of Spanish Ophthalmologists
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will be participating in the 88th Congress of the Society of Spanish Ophthalmologists being held in Barcelona from…
Cloned EHR Notes Jeopardize Medicare Payment
Medicare contractors say they will recoup payment if they discover physicians are electronically recycling chart notes with no regard for accuracy. Medscape Medical News
Aflibercept Improves Visual Acuity in Patients With CRVO
Patients with central retinal vein occlusion (CRVO) achieved a significant improvement in visual acuity who aflibercept in 2 phase 3 clinical trials. Medscape Medical News
How Much Should Doctors REALLY Make?
Some doctors feel that politicians and consumers resent that docs make ‘too much money’ and that some people want doctors to earn less. Realistically speaking, how much should doctors be earning? Medscape Business of Medicine
pSivida reports revenues of $699,000 for fourth quarter 2012
pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced financial results for its fourth quarter and fiscal year ended June 30, 2012.
Ohr commences Phase II clinical trial of Squalamine for wet-AMD
Ohr Pharmaceutical today announced the initiation of a Phase II clinical trial to evaluate the efficacy and safety of Squalamine Eye Drops for the treatment of the wet form of age-related macular degeneration.
Neuroprotection for Low-Tension Glaucoma?
The results are clear, even if the underlying mechanisms are not. Medscape Ophthalmology
Valeant purchases QLT’s Visudyne
Valeant Pharmaceuticals International, Inc. announced today that it has acquired Visudyne, used to treat abnormal growth of leaky blood vessels in the eye caused by wet age-related macular degeneration, from QLT Inc.
Mathematicians Partner With IU Med School To Explore More Efficient Treatments
Mathematical modeling being tested by researchers at the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) and the IU School of Medicine has the potential to impact the knowledge and treatment of several diseases that cont…
Myopia May Protect Against Diabetic Retinopathy
Axial elongation may explain the possible protection from diabetic retinopathy observed in some studies of those with myopia. Medscape Medical News
FDA Approves Eylea for Macular Edema Following CRVO
The FDA decision expands the indication of the angiogenesis inhibitor, which is already approved for neovascular age-related macular degeneration. FDA Approvals
An Added Benefit of Cataract Surgery: Fewer Hip Fractures
A new study finds a lower risk for hip fracture in patients who undergo cataract surgery vs those who do not. Dr. Roger Steinert discusses the findings and what they mean for your patients. Medscape Ophthalmology
Structure and function combined is best for detecting, discriminating glaucoma
An index that combines structure and function measurements can detect perimetric and preperimetric glaucoma more accurately, and can differentiate early, moderate, and advanced disease more successfully than systems that consider either variable alone,…